Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-05 Sale |
2023-09-07 5:37 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
34,853 | $17.58 | $612,624 | 44,066 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-04 5:07 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
26,279 | $22.57 | $593,151 | 951,288 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 9:11 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
1,701 | $25.04 | $42,593 | 79,896 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 9:11 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
26,279 | $24.94 | $655,333 | 977,567 (Indirect Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 4:25 pm |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
2,500 | $28.24 | $70,600 | 24,817 (Direct) |
View |
| 2023-06-09 Sale |
2023-06-13 8:09 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
5,000 | $30.82 | $154,096 | 147,347 (Direct) |
View |
| 2023-06-09 Sale |
2023-06-13 8:09 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
31,279 | $30.72 | $960,928 | 1,002,846 (Indirect Direct) |
View |
| 2023-06-01 Sale |
2023-06-05 6:06 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,201 | $30.64 | $98,070 | 80,828 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:29 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
21,401 | $34.55 | $739,338 | 69,165 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:29 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
21,401 | $34.55 | $739,338 | 84,029 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:29 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
70,447 | $34.55 | $2,433,725 | 1,034,125 (Indirect Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:29 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
21,015 | $34.55 | $726,003 | 152,347 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-02 4:01 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,201 | $31.7 | $101,472 | 63,081 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-04 4:24 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,201 | $32.15 | $102,912 | 66,282 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-09 9:46 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
18,496 | $31.59 | $584,220 | 55,547 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-09 9:46 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
18,517 | $31.59 | $584,884 | 73,222 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-09 9:45 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
21,508 | $31.59 | $679,358 | 123,934 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-09 9:45 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
70,390 | $31.59 | $2,223,360 | 934,264 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-31 Option Award |
2024-02-02 4:46 pm |
2025-02-15 2028-01-31 |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
241,668 | $0 | 333,403 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:45 pm |
2025-02-15 2028-01-31 |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
1,070,001 | $0 | 1,070,001 (Direct) |
View |
| 2023-12-31 Option Award |
2024-01-03 4:50 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
264 | $7.47 | 157,618 (Direct) |
View |
| 2023-12-31 Option Award |
2024-01-03 4:48 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
434 | $7.47 | 91,735 (Direct) |
View |
| 2023-12-31 Option Award |
2024-01-03 4:47 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
264 | $7.47 | 1,025,631 (Direct) |
View |
| 2023-12-15 Tax Withholding |
2023-12-18 4:32 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
4,712 | $8.08 | 157,354 (Direct) |
View |
| 2023-08-11 Tax Withholding |
2023-08-15 4:16 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
11,215 | $18.91 | 91,301 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-15 4:16 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
22,620 | $0 | 91,301 (Direct) |
View |
| 2023-08-11 Tax Withholding |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
9,592 | $18.91 | 78,919 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
19,346 | $0 | 78,919 (Direct) |
View |
| 2023-08-11 Tax Withholding |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
8,901 | $18.91 | 162,066 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
22,620 | $0 | 162,066 (Direct) |
View |
| 2023-08-11 Tax Withholding |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
48,064 | $18.91 | 1,025,367 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
122,143 | $0 | 1,025,367 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
769 | $15.61 | 79,896 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,000 | $15.61 | 148,347 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
1,000 | $15.61 | 977,567 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:25 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
2,500 | $18.12 | 24,817 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:25 pm |
N/A 2032-05-03 |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
2,500 | $0 | 24,817 (Direct) |
View |
| 2022-02-02 Option Award |
2023-05-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
42,349 | $0 | 69,165 (Direct) |
View |
| 2022-02-02 Option Award |
2023-05-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
42,349 | $0 | 84,029 (Direct) |
View |
| 2022-02-02 Option Award |
2023-05-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
175,649 | $0 | 1,034,125 (Direct) |
View |
| 2022-02-02 Option Award |
2023-05-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
52,395 | $0 | 152,347 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:15 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
9,449 | $0 | 36,021 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:15 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
9,449 | $0 | 22,590 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:14 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
9,449 | $0 | 34,521 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:14 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
9,449 | $0 | 22,476 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:14 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
9,449 | $0 | 42,421 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:14 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Coric Vlad Director |
1,575 | $0 | 6,770 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 5:13 pm |
N/A 2033-05-02 |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
9,449 | $0 | 34,521 (Direct) |
View |
| 2023-03-15 Tax Withholding |
2023-03-17 3:22 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
5,341 | $30.65 | 928,923 (Direct) |
View |
| 2023-03-15 Tax Withholding |
2023-03-17 3:21 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,739 | $30.65 | 69,483 (Direct) |
View |
| 2023-03-15 Tax Withholding |
2023-03-17 3:21 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
7,330 | $30.65 | 48,217 (Direct) |
View |
| 2023-03-15 Tax Withholding |
2023-03-17 3:21 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,967 | $30.65 | 120,967 (Direct) |
View |
| 2022-09-22 Option Award |
2023-03-09 9:46 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
42,349 | $0 | 55,547 (Direct) |
View |
| 2022-09-22 Option Award |
2023-03-09 9:46 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
42,349 | $0 | 73,222 (Direct) |
View |
| 2022-09-22 Option Award |
2023-03-09 9:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
52,396 | $0 | 123,934 (Direct) |
View |
| 2022-09-22 Option Award |
2023-03-09 9:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
175,649 | $0 | 934,264 (Direct) |
View |